NEW YORK: Autolysosomnal proteins may be a significant Alzheimer’s disease biomarker, as study findings show patients with the disease exhibited higher levels of the proteins than healthy controls.
“There is an urgent need for biomarkers that accurately detect pathogenic components of Alzheimer’s disease before appearance of neurologic signs. Early treatments directed to such targets could limit or reverse neuronal damage and prevent development of overt [Alzheimer’s disease],” said…